Repligen (Germany) Analysis
| RGN Stock | EUR 142.80 2.95 2.11% |
Repligen has over 124.78 Million in debt which may indicate that it relies heavily on debt financing. Repligen's financial risk is the risk to Repligen stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Repligen's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Repligen's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Repligen Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Repligen's stakeholders.
For most companies, including Repligen, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Repligen, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Repligen's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Repligen's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Repligen is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Repligen to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Repligen is said to be less leveraged. If creditors hold a majority of Repligen's assets, the Company is said to be highly leveraged.
Repligen is fairly valued with Real Value of 137.28 and Hype Value of 139.85. The main objective of Repligen stock analysis is to determine its intrinsic value, which is an estimate of what Repligen is worth, separate from its market price. There are two main types of Repligen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Repligen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Repligen's stock to identify patterns and trends that may indicate its future price movements.
The Repligen stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Repligen's ongoing operational relationships across important fundamental and technical indicators.
Repligen |
Repligen Stock Analysis Notes
About 98.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 141.37. Repligen had not issued any dividends in recent years. Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally. The company was founded in 1981 and is headquartered in Waltham, Massachusetts. REPLIGEN CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 548 people. To find out more about Repligen contact Anthony Hunt at 781 250 0111 or learn more at https://www.repligen.com.Repligen Investment Alerts
| Over 98.0% of the company shares are owned by institutional investors |
Repligen Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.53 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Repligen's market, we take the total number of its shares issued and multiply it by Repligen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Repligen Profitablity
Repligen's profitability indicators refer to fundamental financial ratios that showcase Repligen's ability to generate income relative to its revenue or operating costs. If, let's say, Repligen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Repligen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Repligen's profitability requires more research than a typical breakdown of Repligen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25. Technical Drivers
As of the 15th of January 2026, Repligen holds the Semi Deviation of 1.98, risk adjusted performance of 0.0629, and Coefficient Of Variation of 1260.99. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Repligen, as well as the relationship between them. Please check Repligen jensen alpha, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance to decide if Repligen is priced some-what accurately, providing market reflects its current price of 142.8 per share.Repligen Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Simple Moving Average indicator is calculated by adding the closing price of Repligen for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Repligen short-term fluctuations and highlight longer-term trends or cycles.
Repligen Outstanding Bonds
Repligen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Repligen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Repligen bonds can be classified according to their maturity, which is the date when Repligen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Repligen Predictive Daily Indicators
Repligen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Repligen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 142.8 | |||
| Day Typical Price | 142.8 | |||
| Price Action Indicator | 1.48 | |||
| Period Momentum Indicator | 2.95 |
Repligen Forecast Models
Repligen's time-series forecasting models are one of many Repligen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Repligen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Repligen Debt to Cash Allocation
Many companies such as Repligen, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Repligen has accumulated 124.78 M in total debt with debt to equity ratio (D/E) of 19.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Repligen has a current ratio of 2.14, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Repligen until it has trouble settling it off, either with new capital or with free cash flow. So, Repligen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Repligen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Repligen to invest in growth at high rates of return. When we think about Repligen's use of debt, we should always consider it together with cash and equity.Repligen Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Repligen's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Repligen, which in turn will lower the firm's financial flexibility.Repligen Corporate Bonds Issued
Most Repligen bonds can be classified according to their maturity, which is the date when Repligen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Repligen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Repligen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Repligen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Repligen. By using and applying Repligen Stock analysis, traders can create a robust methodology for identifying Repligen entry and exit points for their positions.
Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally. The company was founded in 1981 and is headquartered in Waltham, Massachusetts. REPLIGEN CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 548 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Repligen to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |